Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

BIOVAXYS ANNOUNCES SHARE CONSOLIDATION

  • BioVaxys Technology Corp. announced a consolidation of its common shares on a ten-to-one basis.
  • Trading of the post-consolidation common shares will begin on the Canadian Securities Exchange on September 11, 2025.
  • The company will have approximately 29,342,496 common shares issued and outstanding after the consolidation.
  • The consolidation was approved by the board of directors of BioVaxys, in accordance with the Business Corporations Act.
Insights by Ground AI
Does this summary seem wrong?

37 Articles

The Courier-TribuneThe Courier-Tribune
+35 Reposted by 35 other sources
Center

BIOVAXYS ANNOUNCES SHARE CONSOLIDATION

VANCOUVER, BC, Sept. 5, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") announces, further to its news release dated August 27, 2025, the consolidation of its common shares ("Common Shares") on the…

Read Full Article
stocktitan.netstocktitan.net

293M to 29.3M Shares: BioVaxys Implements Major 10:1 Stock Consolidation for Clinical-Stage Biotech

Clinical-stage biotech BioVaxys announces 10:1 share consolidation effective Sept 11, reducing outstanding shares from 293.4M to 29.3M. New CUSIP: 09076M200. Includes DPX platform immunotherapies.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 71% of the sources are Center
71% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

PR Newswire broke the news in United States on Friday, September 5, 2025.
Sources are mostly out of (0)

Similar News Topics

Vancouver, British Columbia icon

Vancouver, British Columbia

News
For You
SearchBlindspotLocal